Immunogenicity of indigenous recombinant hepatitis B vaccine in infants following a 0, 1, 2-month vaccination schedule.
Kumar
T S
TS
Department of Child Health, Christian Medical College and Hospital, Vellore 632 004, Tamil Nadu, India.
Abraham
P
P
Raghuraman
S
S
Cherian
T
T
D003257:Consumer Product Safety; D015721:Diphtheria-Tetanus-Pertussis Vaccine / Q000494:pharmacology; D006509:Hepatitis B / Q000276:immunology / Q000517:prevention & control*; D017325:Hepatitis B Vaccines / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007115:Immunization Schedule; D007223:Infant; D007231:Infant, Newborn; D014614:Vaccines, Synthetic / Q000494:pharmacology / Q000627:therapeutic use*
D015721:Diphtheria-Tetanus-Pertussis Vaccine; D017325:Hepatitis B Vaccines; D014614:Vaccines, Synthetic